Life Sciences Real World Evidence (RWE) / Real World Data (RWD) Platforms – Review of Oracle Analytics Intelligence for Life Sciences
Tech Launch Perspective

27 Jan 2025
by Abhishek Singh, Manu Aggarwal, Chunky Satija, Nisarg Shah

Life sciences enterprises are increasingly focusing on Real-world Evidence / Real-world Data (RWE/RWD) to promote patient centricity, identify the next opportunity, and demonstrate value for their investments. Enterprises are seeking next-generation solutions to address interoperability and data access challenges. This shift compels providers to innovate their offerings and introduce advanced solutions that enhance analytics and insights, enable interoperability, and enhance data security. Following suit, Oracle has launched its Analytics Intelligence for Life Sciences offering, which provides AI-enabled workflows, enhanced data interoperability, and pre-integrated datasets.

In this report, we examine Oracle’s current market position, key product announcements, and industry objectives. We also review Oracle’s RWE/RWD technology and cover essential RWE/RWD issues and objectives for life sciences enterprises. 

Scope

  • Industry: life sciences
  • Geography: global
  • Segment: RWE/RWD platforms

Contents

In this report, we examine:

  • Key enterprise RWE/RWD issues and objectives
  • Oracle’s Analytics Intelligence for Life Sciences announcement

Memberships

Life Sciences Information Technology

Sourcing and Vendor Management

 

Page Count: 7